Zimmer Biomet Holdings, Inc. is a musculoskeletal healthcare company. The company design, manufacture and market orthopaedic reconstructive products; sports medicine, biologics, extremities and trauma products; spine, bone healing, craniomaxillofacial and thoracic products; dental implants; and related surgical products. Zimmer Biomet Holdings, Inc., formerly known as Zimmer Holdings, Inc., is based in Warsaw, United States.
Industry sector: Medical
Sector classification: Surgical appliances & supplies
Deep Learning based analysis and prediction model for Zimmer Biomet Holdings, Inc. (ZBH) stock is a 1st Generation Non-linear Autoregresive with exogenous variable(s) (NARX) model based on the Recurrent Neural Network architecture.
Model is in the production pipeline since Oct. 22, 2015.
Market data for ZBH model training are being downloaded from the
Quandl premium datasets on a daily basis.
Risks related to the novel coronavirus disease 2019 (COVID-19) caused by the virus named “SARS-CoV-2” are accounted for in this model in the form of the historical data coincided with outbreaks and other global events in the past used to train ML prediction model for ZBH.
Model is being retrained on a daily basis.
|% Held by Insiders||0.71%|
|% Held by Institutions||86.53%|
|EPS (last reported FY)||$8.03|
|EPS (last reported Q)||$1.91|
|EPS, estimated (last reported Q)||$1.87|
|Total revenues||$8 B|
|Net income||$2 B|